Nuria Martínez Sáez-rekin lankidetzan egindako argitalpenak (9)

2024

  1. Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses

    JACS Au, Vol. 4, Núm. 1, pp. 150-163

2017

  1. In situ characterization of advanced glycation end products (AGEs) in collagen and model extracellular matrix by solid state NMR

    Chemical Communications, Vol. 53, Núm. 100, pp. 13316-13319

  2. The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer

    Journal of the American Chemical Society, Vol. 139, Núm. 50, pp. 18255-18261

2016

  1. Tn Antigen Mimics Based on sp2-Iminosugars with Affinity for an anti-MUC1 Antibody

    Organic Letters, Vol. 18, Núm. 15, pp. 3890-3893

2015

  1. Deciphering the Non-Equivalence of Serine and Threonine O-glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody

    Angewandte Chemie International, Vol. 54, Núm. 34, pp. 9830

  2. Detection of tumor-associated glycopeptides by Lectins: The peptide context modulates carbohydrate recognition

    ACS chemical biology, Vol. 10, Núm. 3, pp. 747-756

2014

  1. Conformational analysis of peptides and glycopeptides derived from the consensus sequence for β-O-glucosylation

    Current Topics in Medicinal Chemistry, Vol. 14, Núm. 23, pp. 2712-2721

  2. Designing non-natural cancer vaccines by replacing the methyl group of Thr-10 in MUC1 derivatives

    XI Carbohydrate Symposium

  3. Serine versus Threonine Glycosylation witha-O-GalNAc: Unexpected Selectivity in Their Molecular Recognition with Lectins

    Chemistry - A European Journal, Vol. 20, Núm. 39, pp. 12616-12627